|
|
|
| home > white papers > How to Reduce Costs of Specialty Pharmaceutical Shipments and Increase Patient Satisfaction - Temptime Corporation |
|
|
 WHITE PAPERS |
|
Temptime Corporation
|
|
How to Reduce Costs of Specialty Pharmaceutical Shipments and Increase Patient Satisfaction
|
|
The specialty pharmacy industry could reduce costs by $27.5 million annually (product and call center staff costs only) if visual temperature indicators were used as decision-making tools to determine if medicine should be used or returned when patients suspect heat damage. In addition, 97% of patients surveyed, who received medicine from specialty pharmacies with a visual temperature indicator included in the package, agree that they would want an indicator in all shipments and 95% agree the indicator increased their confidence in the medicines received.
|
|
|
|
|
|
|
 |
News and Press Releases |
 |
New Controlled-Rate Freezers Provide Optimal Sample Protection and Support GMP and 21 CFR Part 11 Requirements
Waltham, Mass. – (January 11, 2021) – In line with the need for
pharmaceutical research, cell and gene therapy, vaccine production and
biobanking laboratories for dependable sample protection, the new series
of controlled-rate freezers from Thermo Fisher Scientific provides
precise, repeatable freezing capabilities, while enhancing data
traceability to support GMP and 21 CFR part 11 requirements.
More info >> |
|
 |
White Papers |
 |
|
Bio/Pharmaceutical Methods: Do your Analytical Methods Hold Up to Regulatory Scrutiny?
Eurofins BioPharma Product Testing
As FDA guidelines evolve and drug products on the market begin to age, bio/pharmaceutical manufacturers face scrutiny of the original methods used to support these products. Therefore, manufacturers must re-evaluate these methods to ensure they comply with current FDA expectations. Some manufacturers are even facing consent decrees imposed by the agency requiring them to bring methods up to current standards within a specified timeframe. This exercise requires significant amounts of time and resources, which many manufacturers do not have since they are focused on getting their next products to market. For that reason, some clients have been turning to Eurofins Lancaster Laboratories for support.
More info >> |
|
 |
Industry Events |
 |
DIA Europe 2021
15-19 March 2021, VIRTUAL CONFERENCE
DIA Europe is the must-attend event for all life science professionals
working in drug development, from discovery to marketed use. It
encourages open collaboration by bringing together representatives from
the entire spectrum of the life science landscape and facilitating
crucial discussions across several topic tracks: Clinical Development,
Regulatory Strategy, Pharmacovigilance, Value and Access, Health Policy,
and many more.
More info >> |
|
|
|
